The Patent Finder

Inflammatory Response Research, Inc.

Also on record
Records under this name other than the patents Inflammatory Response Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 4 of 4 · Back to Inflammatory Response Research, Inc.

PatentTitleStatus Expires Confidence
US 9,044,479Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,522,148Use of levocetirizine and montelukast in the treatment of traumatic injury
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,669,025Use of levocetirizine and montelukast in the treatment of vasculitis
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,669,026Use of levocetirizine and montelukast in the treatment of autoimmune disorders
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited